These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2474480

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.
    Novick DM, Lok AS, Thomas HC.
    J Hepatol; 1985; 1(1):29-35. PubMed ID: 2414358
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
    Loeschke K, Abb J, Farack UM, Wiebecke B.
    Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
    McDonald JA, Caruso L, Karayiannis P, Scully LJ, Harris JR, Forster GE, Thomas HC.
    Hepatology; 1987 Aug; 7(4):719-23. PubMed ID: 3038722
    [Abstract] [Full Text] [Related]

  • 31. Chronic hepatitis B and adenine arabinoside monophosphate (Ara-AMP).
    Novick DM.
    Ann Intern Med; 1988 Mar; 108(3):492-3. PubMed ID: 2449111
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
    Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, Bréchot C, Ruet C, Kreis H.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1446-9. PubMed ID: 7680158
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy.
    Saracco G, Mazzella G, Rosina F, Cancellieri C, Lattore V, Raise E, Rocca G, Giorda L, Verme G, Gasbarrini G.
    Hepatology; 1989 Sep; 10(3):336-41. PubMed ID: 2668148
    [Abstract] [Full Text] [Related]

  • 38. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP, Regenstein FG, Peters MG, DeSchryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC.
    Ann Intern Med; 1988 Jul 15; 109(2):95-100. PubMed ID: 3289433
    [Abstract] [Full Text] [Related]

  • 39. Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials.
    Müller R, Klein H, Vido I, Niehoff G, Lautz HU, Gebel M, Schmidt FW.
    J Hepatol; 1986 Jul 15; 3 Suppl 2():S217-23. PubMed ID: 2439573
    [No Abstract] [Full Text] [Related]

  • 40. Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection.
    Soike KF, Felsenfeld AD, Gibson S, Gerone PJ.
    Antimicrob Agents Chemother; 1980 Jul 15; 18(1):142-7. PubMed ID: 6158291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.